These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5511214)

  • 21. [Features of disorders of carbohydrate metabolism in progressive muscular dystrophies (review)].
    Badalian LO; Temin PA; Ametov AS; Khasanova KhD; Il'in IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(3):122-6. PubMed ID: 6344519
    [No Abstract]   [Full Text] [Related]  

  • 22. [Carnosine and anserine content of muscles in the course of progressive muscular dystrophy].
    Stepanova NG; Grinio LP
    Vopr Med Khim; 1968; 14(2):210-4. PubMed ID: 5682163
    [No Abstract]   [Full Text] [Related]  

  • 23. Duchenne's muscular dystrophy.
    Leong LL
    Med J Aust; 1968 Jul; 2(4):190-1. PubMed ID: 5670892
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sideremia and muscular myoglobin in progressive muscular dystrophy and other neuromuscular diseases].
    Buscaino GA
    Acta Neurol (Napoli); 1966; 21(1):26-32. PubMed ID: 5999243
    [No Abstract]   [Full Text] [Related]  

  • 25. Prednisone therapy for Duchenne's muscular dystrophy.
    Oexle K
    N Engl J Med; 1989 Nov; 321(21):1481-2. PubMed ID: 2811967
    [No Abstract]   [Full Text] [Related]  

  • 26. Determination of blood flow in muscles using radioactive xenon (133Xe) in cases of progressive muscular dystrophy.
    Kapuścińska B; Kapuściński A; Stroińska B
    Pol Med J; 1970; 9(2):506-11. PubMed ID: 4912387
    [No Abstract]   [Full Text] [Related]  

  • 27. [Biochemical research in progressive muscular dystrophy. I. Study of tissue respiration and the free sulfhydryl groups of muscular tissue].
    Duma D; Popoviciu L; Proinov I; Lazăr TC; Cătană R; Serban M; Mareş V; Abrudan M
    Stud Cercet Neurol; 1966; 11(2):99-105. PubMed ID: 5941631
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on progressive muscular dystrophy. IV. Effects of original amino acids mixture on progressive muscular dystrophy.
    Nakahara M; Yamada S
    Arzneimittelforschung; 1967 Jun; 17(6):753-6. PubMed ID: 5632380
    [No Abstract]   [Full Text] [Related]  

  • 29. [Biochemical studies in progressive muscular dystrophy. II. Changes of glycogen, potassium, and total and residual nitrogen. Oxygen consumption with endogenous and exogenous substrates].
    Duma D; Popoviciu L; Mareş V; Serban M; Pîrvu M; Lazăr TC; Pop R; Băltescu V
    Stud Cercet Neurol; 1967; 12(2):85-91. PubMed ID: 6043564
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic allopurinol and adenine therapy in Duchenne muscular dystrophy: effects on muscle function, nucleotide degradation, and muscle ATP and ADP content.
    Bertorini TE; Palmieri GM; Griffin J; Chesney C; Pifer D; Verling L; Airozo D; Fox IH
    Neurology; 1985 Jan; 35(1):61-5. PubMed ID: 3880875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Distribution of intravenously-injected F59 in the iron-containing proteins of patients with progressive muscular dystrophy].
    INDOVINA I; PATTAVINA C
    Boll Soc Ital Biol Sper; 1953 Apr; 29(4):762-4. PubMed ID: 13106040
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lipid content of human skeletal muscle in primary and secondary myopathies].
    Kunze D; Olthoff D
    Clin Chim Acta; 1970 Sep; 29(3):455-62. PubMed ID: 5496568
    [No Abstract]   [Full Text] [Related]  

  • 33. Electrolyte and lipid composition of skeletal and cardiac muscle in mice with hereditary muscular dystrophy.
    YOUNG HL; YOUNG W; EDELMAN IS
    Am J Physiol; 1959 Aug; 197():487-90. PubMed ID: 13846630
    [No Abstract]   [Full Text] [Related]  

  • 34. Tissue lipids in calves suffering from muscular dystrophy.
    Poukka R
    Br J Nutr; 1966; 20(2):245-56. PubMed ID: 5938703
    [No Abstract]   [Full Text] [Related]  

  • 35. [Carbohydrate metabolism disorders in the muscle tissue of patients with Duchenne's dystrophy].
    Davidenkova EF; Verzhbinskaia NA; Savina MV; Shvarts EI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(10):1441-5. PubMed ID: 5490127
    [No Abstract]   [Full Text] [Related]  

  • 36. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
    Wang S; Shen D
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy.
    Yamazaki M; Minota S; Sakurai H; Miyazono K; Yamada A; Kanazawa I; Kawai M
    Am J Pathol; 1994 Feb; 144(2):221-6. PubMed ID: 8311110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Phospholipid content in the muscles in dystrophy and starvation].
    Kastrykina TF
    Ukr Biokhim Zh; 1965; 37(6):871-8. PubMed ID: 5877233
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current theories on the pathogenesis of muscular dystrophy].
    Davidenkova EF; Shvarts EI; Rozenberg OA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(10):1446-52. PubMed ID: 5139404
    [No Abstract]   [Full Text] [Related]  

  • 40. Alterations in lipid incorporation in Duchenne muscular dystrophy. Studies of fresh and cultured muscle.
    Ionasescu V; Monaco L; Sandra A; Ionasescu R; Burmeister L; Deprosse C; Stern LZ
    J Neurol Sci; 1981 May; 50(2):249-51. PubMed ID: 7229668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.